Back
Savara 10K Form
Buy
61
SVRA
Savara
Last Price:
3.82
Seasonality Move:
34.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | SVRA/Savara Quarterly |
| 2023-08-10 | 10Q | SVRA/Savara Quarterly |
| 2023-05-15 | 10Q | SVRA/Savara Quarterly |
| 2022-11-10 | 10Q | SVRA/Savara Quarterly |
| 2022-08-11 | 10Q | SVRA/Savara Quarterly |
| 2022-05-11 | 10Q | SVRA/Savara Quarterly |
Receive SVRA News And Ratings
See the #1 stock for the next 7 days that we like better than SVRA
SVRA Financial Statistics
Sales & Book Value
| Annual Sales: | $257K |
|---|---|
| Cash Flow: | $-22.52M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.74 |
| Price / Book: | 6.6 |
Profitability
| EPS (TTM): | -0.42000 |
|---|---|
| Net Income (TTM): | $-75.29M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Savara Earnings Forecast
Key Savara Financial Ratios
- The Selling, General & Administrative Expenses for SVRA have been equal to 5,550.19% of Gross Profit Margin.
- The Interest Expense is -0.23% of Operating Income.
- Per Share Earnings over the last 24 years have been positive in 15 years.
Savara Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SVRA |
| CUSIP: | 805111 |
| Website: | savarapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |